Mandate

Vinge advises Alder in connection with its new majority ownership in Powerbox International

August 30, 2013

Powerbox International is one of Europe's leading manufacturers and distributors of power converters and associated products. It now has a new majority owner in Alder, a private equity fund based in Stockholm, Sweden. Founded in 1974, Powerbox International develops, manufactures and markets power supply solutions in AC/DC or DC/DC, ranging from a few watts to tens of kilowatts for demanding applications and customers. The company has an international reach with subsidiaries in 16 countries in Europe, the US and the Asia/Pacific region.

Alder is the new majority owner, with Industrifonden as well as current and previous employees of the company remaining as minority shareholders. Alder is an active investor and will, together with management, develop the company so that it reaches its full potential. As part of the transaction, new capital is invested in the company to help strengthen the organisation to enable future growth.

Vinges team consisted primarily of partners Johan Larsson and Jonas Bergström and associates Gustav Jönsson, Linn Adelwald and Philip Watson.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026